VWA
BIIB icon

V Wealth Advisors’s Biogen BIIB Stock Holding History

V Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-636
Closed -$220K – 543
2021
Q2 		$220K Buy
+636
New +$193K 0.04% 432
2019
Q1 		– Sell
-642
Closed -$209K – 261
2018
Q4 		$209K Buy
642
+47
+8% +$15K 0.11% 198
2018
Q3 		$212K Buy
+595
New +$205K 0.1% 207
2017
Q3 		– Sell
-224
Closed -$60K – 246
2017
Q2 		$60K Sell
224
-6,203
-97% -$1.64M 0.03% 287
2017
Q1 		$1.75M Buy
6,427
+710
+12% +$201K 1.08% 26
2016
Q4 		$1.62M Buy
5,717
+68
+1% +$20.2K 1.19% 25
2016
Q3 		$1.78M Buy
5,649
+152
+3% +$45K 1.44% 16
2016
Q2 		$1.32M Buy
+5,497
New +$1.45M 1.08% 29

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

V Wealth Advisors's BIIB Position: Q3 2021 in Review

V Wealth Advisors sold out of Biogen (BIIB) in Q3 2021, closing a stake of 636 shares — an estimated $220K sold.

V Wealth Advisors first reported a position in BIIB in Q2 2016 and held it in 8 quarters. The position peaked at $1.78M in Q3 2016. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • V Wealth Advisors reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • V Wealth Advisors sold 636 Biogen shares in Q3 2021, an estimated $220K.
  • V Wealth Advisors first reported a position in Biogen in Q2 2016 and held it in 8 quarters.
  • V Wealth Advisors's Biogen position peaked at $1.78M in Q3 2016.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on V Wealth Advisors's 13F filing for Q3 2021, filed 20 Oct 2021.